CHURCHILL MANAGEMENT Corp trimmed its stake in shares of Leidos Holdings, Inc. (NYSE:LDOS – Free Report) by 1.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 12,732 shares of the aerospace company’s stock after selling 196 shares during the period. CHURCHILL MANAGEMENT Corp’s holdings in Leidos were worth $1,834,000 at the end of the most recent reporting period.
Other institutional investors have also modified their holdings of the company. Park Avenue Securities LLC increased its holdings in Leidos by 83.1% during the 4th quarter. Park Avenue Securities LLC now owns 6,064 shares of the aerospace company’s stock valued at $874,000 after acquiring an additional 2,752 shares in the last quarter. Kathmere Capital Management LLC grew its position in shares of Leidos by 64.3% in the fourth quarter. Kathmere Capital Management LLC now owns 4,439 shares of the aerospace company’s stock valued at $640,000 after purchasing an additional 1,738 shares during the last quarter. Board of the Pension Protection Fund purchased a new position in shares of Leidos during the 4th quarter worth approximately $908,000. Oak Thistle LLC acquired a new position in shares of Leidos during the 4th quarter worth approximately $564,000. Finally, Brookstone Capital Management lifted its stake in Leidos by 16.7% in the 4th quarter. Brookstone Capital Management now owns 4,978 shares of the aerospace company’s stock valued at $717,000 after buying an additional 714 shares in the last quarter. Hedge funds and other institutional investors own 76.12% of the company’s stock.
Analyst Ratings Changes
Several equities analysts have weighed in on LDOS shares. Royal Bank of Canada raised their price target on Leidos from $145.00 to $180.00 and gave the stock a “sector perform” rating in a research report on Wednesday, October 30th. TD Cowen downgraded shares of Leidos from a “buy” rating to a “hold” rating and cut their target price for the company from $200.00 to $165.00 in a research note on Wednesday, January 8th. UBS Group started coverage on shares of Leidos in a report on Monday, December 2nd. They issued a “neutral” rating and a $182.00 target price on the stock. Barclays lifted their price target on shares of Leidos from $165.00 to $210.00 and gave the stock an “overweight” rating in a report on Monday, November 4th. Finally, Truist Financial reduced their price objective on shares of Leidos from $205.00 to $185.00 and set a “buy” rating on the stock in a research note on Friday, November 22nd. Five equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $179.07.
Leidos Trading Down 0.2 %
LDOS stock opened at $154.97 on Friday. The company has a quick ratio of 1.15, a current ratio of 1.23 and a debt-to-equity ratio of 0.87. The company has a market cap of $20.68 billion, a price-to-earnings ratio of 17.65, a PEG ratio of 0.98 and a beta of 0.66. The business has a fifty day simple moving average of $158.64 and a 200-day simple moving average of $157.89. Leidos Holdings, Inc. has a 52 week low of $107.73 and a 52 week high of $202.90.
Leidos (NYSE:LDOS – Get Free Report) last announced its quarterly earnings results on Tuesday, October 29th. The aerospace company reported $2.93 EPS for the quarter, topping the consensus estimate of $1.96 by $0.97. The company had revenue of $4.19 billion during the quarter, compared to analyst estimates of $4.06 billion. Leidos had a return on equity of 30.31% and a net margin of 7.37%. The firm’s revenue was up 6.9% on a year-over-year basis. During the same period in the prior year, the firm posted $2.03 earnings per share. On average, equities research analysts expect that Leidos Holdings, Inc. will post 10.03 EPS for the current year.
Leidos Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 31st. Shareholders of record on Monday, December 16th were given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.03%. This is a boost from Leidos’s previous quarterly dividend of $0.38. The ex-dividend date of this dividend was Monday, December 16th. Leidos’s payout ratio is 18.22%.
Insiders Place Their Bets
In other news, Director Surya N. Mohapatra sold 2,748 shares of the company’s stock in a transaction dated Thursday, November 7th. The stock was sold at an average price of $194.97, for a total value of $535,777.56. Following the completion of the sale, the director now owns 20,001 shares of the company’s stock, valued at $3,899,594.97. This represents a 12.08 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Robert C. Kovarik, Jr. sold 1,047 shares of the firm’s stock in a transaction dated Thursday, October 31st. The shares were sold at an average price of $184.94, for a total value of $193,632.18. Following the sale, the director now owns 6,408 shares in the company, valued at approximately $1,185,095.52. The trade was a 14.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.96% of the stock is owned by insiders.
Leidos Company Profile
Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.
Read More
- Five stocks we like better than Leidos
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- How Investors Can Find the Best Cheap Dividend Stocks
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- Short Selling – The Pros and Cons
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for Leidos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leidos and related companies with MarketBeat.com's FREE daily email newsletter.